BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

EpiVax Grants ISPRI Toolkit License to Eisai for Preclinical Immunogenicity Screening

The ISPRI toolkit is a secure web-based platform that allows researchers to rapidly assess the immunogenic risk of biologic candidates. The fu...

December 21, 2023 | News

Roche's Navify Digital Solutions Earn High Ratings in KLAS Research

Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilita...

December 20, 2023 | News

Biorithm Raises $3.5M in Series A to Advance Global Maternal Care

Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...

December 19, 2023 | News

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...

December 18, 2023 | News

Vertex Gets Positive CHMP Opinion for First CRISPR Gene Therapy, CASGEVY™, for Sickle Cell Disease

- If approved by the European Commission, patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thal...

December 15, 2023 | News

Singapore Introduces New Treatment for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation

Pierre Fabre Singapore receives approval from the Ministry of Health (“MOH”), Singapore, for the listing of BRAFTOVI on the Cancer Drug L...

December 15, 2023 | News

Crown Aesthetics Reveals Groundbreaking Study on BIOJUVE™ Skin Microbiome-Optimized Regimen

Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced that its groundbreaking clinical study, recently accepted for publication i...

December 14, 2023 | News

Virtual twin to improve treatment with cancer immunotherapies

In recent years, cancer immunotherapies have established themselves as a further pillar of medical oncology alongside traditional treatment options (surger...

December 14, 2023 | News

Inside the World of Cell Therapies: Illuminating the Future of Cancer Care

The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...

December 13, 2023 | News

First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging

The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...

December 12, 2023 | News

CSL Behring's HEMGENIX® Shows Long-Term Durability and Safety in Hemophilia B

HEMGENIX® is the first and only gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of he...

December 12, 2023 | News

Thermo Fisher Unveils Automated Solutions for Respiratory Testing

New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories. ...

December 12, 2023 | News

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

The Rare Disease Diagnosis and Intractable Disease Research Center at Juntendo University has improved its diagnostic capabilities by combining research ...

December 11, 2023 | News

Sirnaomics Successfully Completes Phase I Study for Anticoagulant RNAi Therapeutic STP122G

Cohort 1 is comprised of eight subjects who completed dosing and were followed over a period of 140 days. Safety data showed there were no dose-limiting to...

December 06, 2023 | News

Stay Connected